PICo SM Study
Research type
Research Study
Full title
The Psychological Impact of COVID-19 on Patients with Solid Malignancies: A Single-Institution Survey Study
IRAS ID
292413
Contact name
Konstantinos-Vellios Kamposioras
Contact email
Clinicaltrials.gov Identifier
CFTSp196, Christie sponsor reference
Duration of Study in the UK
0 years, 11 months, 1 days
Research summary
The COVID-19 pandemic and the subsequent government-imposed restrictions have undeniably resulted in unprecedented changes to the life of patients with cancer. It has become more evident that patients with cancer may be at significant risk of higher morbidity and mortality when infected with SARS-CoV-2, which is understandably causing anxiety amongst both patients and their oncology team. In this project, we aim to evaluate the impact of COVID-19 on the mental health and general wellbeing of patients diagnosed with solid malignancies by utilising a range of non-invasive questionnaires (GAD-7, PHQ-9, PC-PTSD-5, WHO-5 and wellbeing thermometer) at two time points and referral to support services when needed. This study is designed to be reactive and adaptive to an ever-changing situation. It is essential to understand both the short- and long- term psychological consequences of COVID-19 on our patients to better inform the institute, and other regional and national stakeholders of the scale of the issue, in order to recommend necessary measures and resources required to address this important issue.
REC name
Wales REC 7
REC reference
21/WA/0021
Date of REC Opinion
29 Jan 2021
REC opinion
Favourable Opinion